data_3eza_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3eza _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.366 -0.605 . . . . 3.53 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.94 129.92 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.949 -0.76 . . . . 1.56 108.949 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -129.96 141.77 50.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.203 -0.936 . . . . 1.17 110.451 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 108.334 -1.907 . . . . 0.64 108.334 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 81.8 mt -94.99 -12.07 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.759 -1.436 . . . . 1.31 111.041 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.1 tp 53.36 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.14 -0.975 . . . . 1.25 109.579 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.58 -25.49 16.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.274 -0.891 . . . . 1.29 109.821 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.78 126.4 10.35 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.222 -0.924 . . . . 1.81 108.87 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 142.81 15.56 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.005 1.803 . . . . 0.64 111.774 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.35 -160.85 33.53 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.665 -1.774 . . . . 0.57 108.665 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.3 mt -149.52 150.14 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.242 . . . . 1.19 108.252 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.18 154.68 31.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.782 -1.199 . . . . 1.08 111.185 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.78 126.81 31.42 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.145 -1.057 . . . . 0.67 108.145 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.86 178.67 48.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.678 -1.725 . . . . 0.39 110.921 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.75 159.97 26.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.756 -0.849 . . . . 2.3 109.224 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.8 129.06 53.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.317 -0.864 . . . . 1.11 111.106 -178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.93 134.69 43.53 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.806 -1.183 . . . . 1.15 107.806 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.92 122.41 44.24 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 1.14 110.542 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.74 103.44 15.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.631 -0.668 . . . . 1.16 110.266 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.41 134.93 40.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.412 -0.805 . . . . 2.5 109.249 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.78 130.54 43.85 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.124 -0.985 . . . . 2.32 109.381 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.91 147.41 38.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.878 -1.138 . . . . 2.07 109.375 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.25 140.19 57.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 2.09 109.341 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -79.31 130.19 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.456 -0.777 . . . . 1.19 109.522 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.04 126.45 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 1.21 109.748 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -105.78 136.87 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.818 -0.808 . . . . 1.2 108.818 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.04 121.22 33.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 1.23 109.95 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.58 -3.23 58.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 3.18 108.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.31 139.57 58.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 2.35 109.174 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 2.71 109.1 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -95.18 165.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 1.14 110.301 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.3 p -96.24 173.11 7.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.379 -0.971 . . . . 0.97 108.379 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.25 78.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 1.2 109.541 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.46 -29.99 51.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.784 -1.197 . . . . 2.18 109.176 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.79 -10.35 58.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 1.26 110.728 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.88 -52.76 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.613 -1.304 . . . . 1.12 108.677 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.29 -40.13 89.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.293 -0.879 . . . . 1.23 110.103 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.02 80.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.014 -1.054 . . . . 2.56 110.793 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -65.31 -40.15 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.746 -1.221 . . . . 1.24 110.031 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.36 -46.79 94.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.791 -1.193 . . . . 1.22 108.558 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.03 -41.34 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.868 . . . . 1.32 109.491 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.13 -44.18 95.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.999 -1.063 . . . . 3.4 108.187 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.834 -0.802 . . . . 0.79 108.834 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.43 -44.36 97.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.377 -0.827 . . . . 1.36 108.81 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.958 -1.089 . . . . 1.08 109.228 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.96 -40.21 84.5 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.729 -1.748 . . . . 0.49 108.729 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.0 ttt-85 -65.54 -31.93 73.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 3.38 108.251 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.08 90.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.922 -0.77 . . . . 1.35 108.922 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.6 ttpt -63.8 -73.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.881 -1.137 . . . . 2.31 108.186 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.5 -33.72 0.11 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.316 -0.865 . . . . 1.14 111.202 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.56 -56.06 27.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.658 -1.276 . . . . 1.98 108.144 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.97 76.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.535 -0.728 . . . . 1.15 111.391 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.35 -40.17 85.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.688 -1.257 . . . . 1.97 110.214 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.14 -40.22 95.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 1.15 108.845 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -61.25 -38.07 85.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.491 -0.756 . . . . 1.17 109.835 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.8 m -63.0 -41.41 99.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 1.13 109.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.51 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.74 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.89 . . . . 1.14 109.511 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -56.96 -51.32 69.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 1.57 109.818 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.42 -33.99 70.28 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -0.838 . . . . 1.21 110.462 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -69.63 -37.48 76.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.851 -1.155 . . . . 2.18 109.345 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.85 90.46 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.468 -0.77 . . . . 1.07 109.572 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.35 59.37 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.504 -1.038 . . . . 0.38 110.504 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.95 -45.2 67.96 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.239 . . . . 1.18 109.754 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.5 m -65.78 -63.16 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 1.1 112.031 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.51 -48.66 5.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.031 -1.043 . . . . 0.48 111.66 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.06 -168.74 25.59 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.575 -1.298 . . . . 0.38 111.404 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.07 -24.69 63.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.841 -0.799 . . . . 1.2 109.896 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' OE1' ' NH1' ' B' ' 17' ' ' ARG . 53.5 tp10 -61.05 -36.38 79.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 1.22 109.673 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -97.76 -20.88 17.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.368 -0.832 . . . . 2.33 110.581 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -67.17 -43.56 81.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.044 -1.035 . . . . 1.25 110.858 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.48 67.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 1.07 111.227 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -39.46 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 117.827 -1.549 . . . . 1.13 108.471 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -65.53 -38.72 90.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 1.06 109.732 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.73 -40.24 87.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.835 -1.166 . . . . 1.18 109.24 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -47.94 85.1 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.744 -1.742 . . . . 0.3 108.744 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -60.87 -45.61 93.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.522 -0.987 . . . . 0.69 109.063 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.48 -47.09 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 1.1 109.032 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttp -60.1 -40.07 88.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.067 -1.021 . . . . 1.06 109.805 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.432 ' CD1' ' CE2' ' B' ' 48' ' ' PHE . 60.4 tp -65.54 -40.08 92.48 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.299 -0.876 . . . . 1.13 109.567 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.1 -39.3 94.3 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.69 -0.631 . . . . 1.12 109.948 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.95 5.75 20.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 1.26 110.045 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -50.89 130.15 24.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 1.16 109.587 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.79 -19.15 58.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 1.35 110.697 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -71.22 -35.89 71.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.923 -1.11 . . . . 1.36 109.522 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.17 -39.98 74.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.545 -0.722 . . . . 1.08 110.064 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.63 -48.31 82.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.801 . . . . 1.24 109.455 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -69.91 -40.99 75.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 0.72 110.856 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.06 -40.13 75.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.036 -1.04 . . . . 1.2 111.806 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.5 mt -67.57 -45.72 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.183 . . . . 1.12 109.16 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.86 -39.23 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 1.16 110.863 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.19 -47.86 84.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.983 . . . . 1.15 111.171 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 96' ' ' LYS . 19.7 mt -60.8 -45.95 92.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.864 -1.147 . . . . 1.2 109.866 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.3 mt -61.26 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 1.09 108.407 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -41.99 76.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.449 -0.782 . . . . 2.46 110.628 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 91' ' ' ALA . 51.9 t0 -81.95 -50.89 8.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.856 -1.153 . . . . 1.21 112.153 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.442 ' N ' ' O ' ' A' ' 92' ' ' LEU . 17.6 mttp -91.62 -2.01 57.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.934 -1.104 . . . . 2.6 112.203 -177.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.6 m170 55.16 38.89 31.14 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.025 -1.047 . . . . 2.1 109.832 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtp -93.13 169.8 10.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.902 -0.59 . . . . 1.98 109.597 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.2 p -81.01 159.83 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.143 -0.973 . . . . 1.13 109.79 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.29 83.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 1.14 110.707 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.53 -34.3 72.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.827 -1.171 . . . . 2.18 109.633 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 -40.46 25.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.922 -1.111 . . . . 1.18 109.48 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.32 -46.15 64.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 1.12 110.056 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.0 89.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 1.15 109.738 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.522 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.9 t60 -59.66 -40.18 86.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.8 109.892 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.84 -40.2 96.03 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 1.26 110.311 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 -54.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.887 . . . . 1.14 111.131 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.65 -40.63 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.851 -1.156 . . . . 1.15 109.223 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.98 -39.53 93.61 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.636 -0.876 . . . . 1.91 108.636 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.71 -49.38 74.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.104 -1.198 . . . . 0.45 110.104 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -67.02 -52.9 36.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.782 -1.422 . . . . 1.95 109.346 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.39 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 1.17 108.863 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.0 t -59.64 -40.28 87.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.296 -0.877 . . . . 1.85 108.885 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.85 95.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.173 -0.955 . . . . 1.14 109.077 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.59 -40.09 96.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 1.15 109.738 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.501 -1.374 . . . . 1.68 109.619 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.46 -20.4 12.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.139 -0.976 . . . . 1.39 108.648 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.16 147.37 51.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 1.25 109.575 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.53 40.6 1.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.781 . . . . 2.35 109.897 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.302 -0.874 . . . . 1.26 110.241 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.1 -30.03 67.13 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.354 0.597 . . . . 2.54 110.443 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 4.3 t80 -71.91 -40.06 69.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 1.36 110.595 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -73.86 -34.66 64.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.096 -1.002 . . . . 1.27 108.63 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -62.04 -42.09 98.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 2.56 110.505 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -60.45 -44.56 95.7 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.638 -1.289 . . . . 2.33 109.861 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.56 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 26.8 mtp180 -59.94 -36.06 76.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.849 -1.157 . . . . 2.68 108.397 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.98 67.5 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.097 -1.075 . . . . 1.25 108.097 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.22 -40.07 74.75 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.725 -0.842 . . . . 1.18 108.725 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.42 -40.0 89.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 1.31 109.382 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.34 -40.18 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.85 -0.796 . . . . 1.13 108.85 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -60.02 -40.37 89.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.371 -0.831 . . . . 3.39 109.391 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.93 -39.57 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.598 -0.688 . . . . 1.2 110.168 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.7 -45.36 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 1.14 109.89 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.52 63.09 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.287 -1.125 . . . . 0.4 110.287 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -59.55 -47.78 84.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.353 -1.086 . . . . 2.94 109.557 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.51 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.7 mtp180 -69.92 -31.06 68.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 3.31 109.953 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.03 -42.12 84.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 1.13 108.732 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.93 -40.13 92.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.21 -0.931 . . . . 1.14 109.244 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.869 -1.133 . . . . 3.35 108.652 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.14 -38.02 87.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.54 -0.725 . . . . 1.28 111.295 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.1 -43.53 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.421 -1.424 . . . . 1.12 108.012 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.04 -32.87 69.72 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 1.25 109.149 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.1 42.37 7.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.009 -1.636 . . . . 0.47 109.009 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.55 148.59 40.73 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.572 -0.957 . . . . 1.24 110.647 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.09 138.74 58.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.311 0.576 . . . . 2.87 110.577 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.13 127.46 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.348 1.071 . . . . 1.25 108.204 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.23 -39.91 85.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.533 -0.758 . . . . 1.58 110.562 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.63 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 1.23 109.188 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.41 -0.8 27.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 1.29 110.318 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -14.92 44.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.633 -1.292 . . . . 1.92 109.964 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.22 28.46 0.45 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.006 -1.059 . . . . 1.25 111.314 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.7 mm -89.2 119.77 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.319 -1.488 . . . . 2.02 110.039 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.93 -13.04 18.48 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.277 -0.889 . . . . 2.77 110.491 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.5 151.45 48.84 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.036 -1.04 . . . . 1.29 110.712 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.12 134.02 54.09 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.538 -0.912 . . . . 1.2 108.538 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.8 165.23 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 1.1 110.068 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.99 146.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.427 -2.064 . . . . 1.07 105.427 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.7 tp -99.27 117.76 34.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.039 -1.038 . . . . 1.16 110.376 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.5 t -121.06 129.86 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.777 -0.823 . . . . 1.12 108.777 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.26 160.92 39.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 1.13 109.253 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.21 79.95 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.28 -1.513 . . . . 1.13 107.958 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.37 146.57 2.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.729 -0.841 . . . . 2.09 108.729 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 mt -112.79 138.22 49.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.384 -0.823 . . . . 1.18 110.015 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.4 p -93.99 146.29 31.4 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.886 . . . . 1.24 108.723 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -39.8 -36.48 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.15 1.9 . . . . 0.53 112.562 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 75.4 m -59.75 -40.33 87.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.53 110.342 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.98 -40.72 78.64 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 1.22 110.011 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.1 p -55.45 -30.96 61.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 1.14 111.683 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.61 -52.84 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.798 -1.189 . . . . 1.1 110.339 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.49 36.95 0.61 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.419 -0.801 . . . . 0.75 108.971 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.66 138.88 41.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.657 -0.652 . . . . 1.3 109.472 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.94 102.27 13.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.138 -0.976 . . . . 2.33 109.586 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.6 mt -65.06 -40.66 95.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.958 . . . . 1.28 110.624 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.39 -29.78 67.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.814 -1.179 . . . . 2.54 112.018 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.2 -7.5 45.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.693 -1.254 . . . . 2.45 110.319 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 79.4 t -102.11 113.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.404 -1.332 . . . . 1.12 107.404 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.75 6.82 22.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.074 -1.016 . . . . 1.24 110.833 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.9 174.73 37.75 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.35 -1.5 . . . . 0.33 109.35 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -134.42 129.39 35.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -1.02 . . . . 0.57 108.447 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.2 mt -132.04 126.24 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.766 . . . . 1.08 109.086 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.7 p -149.91 162.13 40.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.838 -1.164 . . . . 1.12 111.0 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.58 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.42 24.85 10.97 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.47 -0.567 . . . . 2.13 109.47 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.31 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.67 -1.269 . . . . 1.32 111.207 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.65 -53.25 6.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.565 -1.014 . . . . 0.72 110.565 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.45 -144.58 8.26 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.092 -1.528 . . . . 0.89 110.668 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.66 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -65.63 -25.41 67.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.032 . . . . 4.37 109.654 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 44.8 p -65.1 2.99 0.66 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.134 -0.979 . . . . 1.61 109.192 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 186' ' ' ARG . 20.5 t -92.09 131.69 37.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.351 -0.843 . . . . 1.73 110.225 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -47.95 -54.56 12.39 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.302 -0.874 . . . . 0.56 110.896 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 t -56.04 -35.25 66.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.231 -0.918 . . . . 2.09 110.8 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.12 -40.34 89.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.925 -1.109 . . . . 1.85 110.507 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.69 -38.15 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 1.95 109.144 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 97.9 mtp -60.26 -40.73 91.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 1.51 110.728 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.4 87.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.685 -1.259 . . . . 1.18 108.471 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -60.67 -58.23 9.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 3.51 109.46 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.3 m -63.13 -39.78 95.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 1.14 111.457 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.94 -23.32 62.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.824 -1.172 . . . . 1.33 109.494 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 64.68 49.33 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 1.43 110.148 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.88 143.94 46.93 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 107.774 -1.195 . . . . 1.19 107.774 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.29 137.51 79.09 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 121.857 1.705 . . . . 0.92 112.09 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.38 150.66 2.92 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.026 -1.046 . . . . 1.08 111.441 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.34 148.67 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 107.832 -1.173 . . . . 1.15 107.832 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.26 -9.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.999 -1.063 . . . . 1.19 110.261 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.99 23.57 16.44 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.914 -0.874 . . . . 0.54 110.914 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.6 p -44.55 -43.78 8.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.286 . . . . 1.14 109.965 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.55 -50.82 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.368 -0.92 . . . . 0.65 111.079 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.78 40.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.624 -1.516 . . . . 2.02 111.19 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.13 -41.07 30.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 1.15 109.535 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.465 ' HG1' ' N ' ' A' ' 210' ' ' SER . 2.6 p -56.96 -30.55 64.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 1.17 110.671 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.465 ' N ' ' HG1' ' A' ' 209' ' ' THR . 14.5 t -77.41 -13.2 59.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.827 -1.171 . . . . 1.83 109.32 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.45 -12.78 17.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.647 -0.658 . . . . 2.66 109.692 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 87.1 t -109.66 141.67 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.773 0.797 . . . . 1.39 111.273 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.4 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 105.752 -1.944 . . . . 2.66 105.752 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 51.3 p-10 -60.97 152.4 27.87 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.176 -1.577 . . . . 2.66 108.837 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 75.16 9.88 3.78 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 120.784 0.326 . . . . 2.28 110.811 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.89 143.42 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 1.96 107.955 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -91.75 122.05 33.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.837 -1.172 . . . . 1.05 107.837 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 77.7 mt -129.92 147.89 51.73 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 1.17 110.419 -178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.89 126.06 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.235 -1.765 . . . . 1.17 106.235 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.3 tp -98.67 118.1 34.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 1.17 109.43 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.492 ' C ' ' H ' ' A' ' 223' ' ' VAL . 29.7 m-20 -75.79 -45.15 37.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.296 -0.878 . . . . 2.2 108.735 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.8 14.44 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.653 -0.869 . . . . 1.12 108.653 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.492 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.6 t -129.58 -46.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.172 -1.418 . . . . 1.21 107.172 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -97.41 0.89 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.478 -1.675 . . . . 2.37 106.478 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.61 10.7 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.857 -0.611 . . . . 2.16 109.584 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.02 155.52 50.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.431 -0.793 . . . . 2.21 109.754 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.17 130.05 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.441 -0.948 . . . . 1.2 108.441 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.76 122.77 45.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 1.11 109.549 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.98 113.84 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.693 . . . . 1.19 110.602 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 54.17 67.08 3.71 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.128 -0.982 . . . . 1.96 110.772 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.19 144.39 4.95 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.864 2.376 . . . . 0.95 112.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.57 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 2.0 109.428 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.71 86.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 2.96 109.788 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.97 -36.8 77.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 2.78 109.584 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.47 -40.43 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.018 . . . . 1.39 109.317 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.69 -45.75 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 1.29 109.068 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -45.16 75.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.275 -1.009 . . . . 2.12 108.275 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.57 -40.35 96.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 2.72 109.001 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.1 mtp -69.9 -31.55 69.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.338 -0.851 . . . . 1.26 109.967 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.48 -39.96 81.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 3.19 109.972 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.46 89.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 1.55 108.699 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.66 -40.06 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.55 109.342 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.37 -39.83 88.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 2.22 108.711 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.65 -39.92 90.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 1.78 108.946 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.1 -43.13 99.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.95 . . . . 2.87 108.523 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.54 96.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.489 -0.757 . . . . 1.9 109.634 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.67 95.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 2.14 108.993 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.8 t -63.52 -39.98 95.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 2.97 109.0 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 3.24 109.614 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.09 -0.707 . . . . 2.28 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -152.6 151.03 30.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.197 -0.939 . . . . 0.83 109.385 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -149.98 159.95 44.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 2.44 110.809 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -153.8 150.46 28.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.618 -0.676 . . . . 2.72 109.608 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.49 131.13 55.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.289 -0.882 . . . . 2.12 110.137 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.88 121.92 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 122.266 1.031 . . . . 1.13 112.392 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 74.1 m -77.85 105.24 8.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.832 0.825 . . . . 1.16 110.545 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.04 122.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.447 1.118 . . . . 1.15 110.628 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' THR . . . . . . . . . . . . . 67.3 p -109.16 19.98 18.86 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.198 -0.91 . . . . 1.21 110.231 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.86 116.58 56.77 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.202 -1.036 . . . . 1.23 108.202 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.14 -13.38 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.173 1.097 . . . . 1.19 113.208 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -119.91 11.24 11.76 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.454 -0.779 . . . . 2.1 109.297 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 177.26 34.2 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.758 -1.737 . . . . 0.5 108.758 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LEU . . . . . 0.512 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.2 tp -83.72 88.02 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.076 -1.249 . . . . 1.14 108.098 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -90.43 -162.59 0.91 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.831 -1.168 . . . . 0.4 110.536 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -41.7 82.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.121 -0.987 . . . . 1.11 112.215 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.47 HH11 ' HG2' ' B' ' 17' ' ' ARG . 1.8 tpt180 -60.15 -59.97 12.13 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.517 -1.364 . . . . 2.13 111.715 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.59 -32.48 87.62 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 120.339 1.157 . . . . 0.39 112.213 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.83 72.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.018 . . . . 1.1 108.445 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.46 64.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.906 -0.718 . . . . 1.1 109.272 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.3 -39.97 64.89 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.215 -0.994 . . . . 2.84 108.5 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -60.65 -50.71 72.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.63 110.041 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 66.4 t -67.89 -28.91 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.902 -1.124 . . . . 1.1 109.731 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -60.31 -45.77 92.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 1.79 109.691 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.64 -47.77 79.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 1.89 110.245 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.56 56.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.112 -0.992 . . . . 1.08 111.55 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.01 -12.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.761 -1.212 . . . . 1.8 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.2 -22.54 73.39 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.76 109.14 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -106.05 142.74 35.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.469 -1.018 . . . . 0.88 109.093 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.499 ' H ' ' HG1' ' B' ' 30' ' ' THR . 0.2 OUTLIER -91.4 -11.53 37.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 2.08 109.491 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 30.2 p -63.28 152.76 36.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 1.87 109.817 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.25 131.94 45.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.516 -0.92 . . . . 2.43 108.516 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.94 131.13 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.409 -0.807 . . . . 1.15 109.096 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.5 m -128.07 147.7 50.54 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.102 -0.703 . . . . 1.09 109.102 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.78 140.93 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.003 -1.851 . . . . 1.14 106.003 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -130.56 122.76 28.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.2 109.506 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 6.9 p -137.81 122.22 18.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.59 110.317 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 39.77 64.33 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.652 . . . . 2.92 112.087 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.09 -10.07 4.83 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.464 -1.397 . . . . 0.7 113.565 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -112.39 123.98 51.49 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.469 1.634 . . . . 2.75 109.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.51 145.0 48.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.375 -0.828 . . . . 1.68 109.734 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.0 164.64 29.73 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.607 0.717 . . . . 1.13 110.502 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 131.47 34.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.713 -0.617 . . . . 1.74 109.825 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' B' ' 46' ' ' SER . . . -71.51 -16.27 62.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.983 -1.073 . . . . 1.1 110.004 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -90.05 21.3 3.76 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.583 -1.636 . . . . 2.89 106.583 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' SER . . . . . 0.433 ' H ' ' C ' ' B' ' 44' ' ' ALA . 29.1 m -145.09 92.22 2.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.867 0.842 . . . . 1.81 111.424 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.431 ' O ' ' OE1' ' B' ' 51' ' ' GLN . 54.2 tp -60.1 -35.94 76.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.003 -0.74 . . . . 1.18 109.003 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.432 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 64.8 m-85 -55.55 -51.57 66.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.369 -0.832 . . . . 0.38 110.008 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.43 ' O ' ' OG1' ' B' ' 52' ' ' THR . 8.3 mtmm -70.29 -40.04 74.52 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.002 -1.061 . . . . 1.85 109.909 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' B' ' 52' ' ' THR . 48.6 mt -50.28 -53.12 30.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.53 -1.356 . . . . 1.12 108.988 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLN . . . . . 0.544 ' CD ' HH21 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -41.93 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.217 -0.927 . . . . 2.54 110.653 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' THR . . . . . 0.538 ' N ' ' O ' ' B' ' 50' ' ' LEU . 67.0 p -84.53 -9.9 57.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.466 -1.396 . . . . 1.08 110.449 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.2 mt -94.75 117.46 30.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.892 -1.13 . . . . 1.13 109.223 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.81 91.92 0.8 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.475 -1.85 . . . . 0.43 108.475 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 mt -100.25 93.03 5.48 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.153 -1.204 . . . . 1.16 109.578 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -93.92 178.41 5.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.061 -1.025 . . . . 1.23 111.163 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.43 113.67 6.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.551 -0.718 . . . . 2.25 110.262 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.04 9.06 43.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.492 -1.443 . . . . 0.74 109.492 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 34.4 m -86.35 109.59 19.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -1.154 . . . . 1.17 110.491 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 44.0 t -77.25 115.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.252 1.025 . . . . 1.15 109.046 -177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.0 m -110.15 176.57 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.827 -1.175 . . . . 1.13 107.827 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -131.61 129.82 41.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.895 -1.15 . . . . 1.07 107.895 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -103.51 118.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.843 -1.54 . . . . 1.12 106.843 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -119.74 132.54 55.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.835 -0.802 . . . . 1.71 108.835 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.13 151.46 38.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 1.12 109.866 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.45 124.14 12.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.6 -0.889 . . . . 2.09 108.6 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.47 -160.24 31.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.468 -1.349 . . . . 0.67 110.711 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.17 -49.94 75.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.165 -0.609 . . . . 2.15 112.329 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -106.92 11.01 30.39 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.786 -1.196 . . . . 1.51 111.566 -177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -40.67 -34.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 2.17 111.909 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.83 -42.3 73.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.682 -1.262 . . . . 2.93 110.613 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -68.91 -52.07 33.25 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.985 -1.072 . . . . 3.04 108.883 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.93 -36.44 7.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.594 -0.691 . . . . 1.17 111.555 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.421 ' O ' ' CG2' ' B' ' 78' ' ' VAL . 99.7 t -80.74 -37.73 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.391 -1.443 . . . . 1.22 109.984 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.19 -38.15 78.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.761 -1.212 . . . . 2.19 110.917 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -82.3 -47.04 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.52 -1.362 . . . . 2.19 110.622 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.84 -37.72 80.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.734 -1.229 . . . . 1.17 109.229 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.421 ' CG2' ' O ' ' B' ' 74' ' ' VAL . 47.6 t -62.48 -43.93 98.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.224 -0.922 . . . . 1.23 109.22 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' B' ' 83' ' ' GLU . 93.5 mttt -70.24 -56.14 7.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 2.67 107.89 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 tp -54.01 -31.76 52.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 1.16 109.328 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.5 ttm -74.25 -38.42 63.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.66 -1.275 . . . . 2.1 108.256 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.55 -5.39 57.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.297 -0.877 . . . . 1.27 110.134 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 79' ' ' LYS . 2.9 mm-40 -110.24 -2.26 16.89 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.985 -1.072 . . . . 2.17 111.631 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 mt -83.28 129.98 35.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.379 -1.451 . . . . 1.58 109.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 117.941 -1.028 . . . . 2.44 109.523 -179.314 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.366 -0.605 . . . . 3.09 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.94 129.92 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.949 -0.76 . . . . 1.03 108.949 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -129.96 141.77 50.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.203 -0.936 . . . . 0.7 110.451 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 108.334 -1.907 . . . . 0.52 108.334 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.8 mt -94.99 -12.07 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.759 -1.436 . . . . 0.69 111.041 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.1 tp 53.36 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.14 -0.975 . . . . 0.57 109.579 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.58 -25.49 16.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.274 -0.891 . . . . 0.72 109.821 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.78 126.4 10.35 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.222 -0.924 . . . . 1.35 108.87 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 142.81 15.56 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.005 1.803 . . . . 0.6 111.774 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.35 -160.85 33.53 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.665 -1.774 . . . . 0.51 108.665 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.3 mt -149.52 150.14 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.242 . . . . 0.59 108.252 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.18 154.68 31.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.782 -1.199 . . . . 0.38 111.185 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.78 126.81 31.42 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.145 -1.057 . . . . 0.57 108.145 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.86 178.67 48.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.678 -1.725 . . . . 0.36 110.921 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.75 159.97 26.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.756 -0.849 . . . . 1.8 109.224 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.8 129.06 53.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.317 -0.864 . . . . 0.4 111.106 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.93 134.69 43.53 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.92 122.41 44.24 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.46 110.542 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.74 103.44 15.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.631 -0.668 . . . . 0.53 110.266 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.41 134.93 40.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.412 -0.805 . . . . 2.01 109.249 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.78 130.54 43.85 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.124 -0.985 . . . . 2.32 109.381 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.91 147.41 38.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.878 -1.138 . . . . 2.07 109.375 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.25 140.19 57.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 2.09 109.341 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -79.31 130.19 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.456 -0.777 . . . . 0.54 109.522 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.04 126.45 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.6 109.748 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -105.78 136.87 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.818 -0.808 . . . . 0.49 108.818 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.04 121.22 33.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 1.23 109.95 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.58 -3.23 58.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 2.6 108.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.31 139.57 58.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 1.83 109.174 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 2.18 109.1 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -95.18 165.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.44 110.301 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.3 p -96.24 173.11 7.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.379 -0.971 . . . . 0.54 108.379 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.25 78.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.6 109.541 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.46 -29.99 51.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.784 -1.197 . . . . 2.18 109.176 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.79 -10.35 58.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.87 110.728 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.88 -52.76 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.613 -1.304 . . . . 0.43 108.677 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.29 -40.13 89.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.293 -0.879 . . . . 1.23 110.103 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.02 80.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.014 -1.054 . . . . 2.12 110.793 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 31' ' ' ILE . 60.1 mm-40 -65.31 -40.15 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.746 -1.221 . . . . 1.24 110.031 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.36 -46.79 94.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.791 -1.193 . . . . 0.5 108.558 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.03 -41.34 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.868 . . . . 1.32 109.491 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.13 -44.18 95.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.999 -1.063 . . . . 2.94 108.187 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 65.7 t80 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.834 -0.802 . . . . 0.68 108.834 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.43 -44.36 97.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.377 -0.827 . . . . 0.72 108.81 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.958 -1.089 . . . . 0.7 109.228 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.96 -40.21 84.5 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.729 -1.748 . . . . 0.46 108.729 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 47' ' ' ARG . 37.0 ttt-85 -65.54 -31.93 73.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 2.82 108.251 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.08 90.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.922 -0.77 . . . . 0.72 108.922 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.6 ttpt -63.8 -73.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.881 -1.137 . . . . 1.87 108.186 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.5 -33.72 0.11 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.316 -0.865 . . . . 0.39 111.202 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.56 -56.06 27.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.658 -1.276 . . . . 1.46 108.144 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.97 76.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.535 -0.728 . . . . 0.44 111.391 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.35 -40.17 85.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.688 -1.257 . . . . 1.27 110.214 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.14 -40.22 95.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.46 108.845 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -61.25 -38.07 85.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.491 -0.756 . . . . 1.17 109.835 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.8 m -63.0 -41.41 99.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.41 109.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.527 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.74 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.89 . . . . 0.42 109.511 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -56.96 -51.32 69.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 0.96 109.818 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.42 -33.99 70.28 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -0.838 . . . . 0.51 110.462 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -69.63 -37.48 76.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.851 -1.155 . . . . 1.63 109.345 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.85 90.46 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.468 -0.77 . . . . 0.35 109.572 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.35 59.37 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.504 -1.038 . . . . 0.37 110.504 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.95 -45.2 67.96 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.239 . . . . 1.18 109.754 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.5 m -65.78 -63.16 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.39 112.031 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.51 -48.66 5.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.031 -1.043 . . . . 0.43 111.66 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.06 -168.74 25.59 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.575 -1.298 . . . . 0.36 111.404 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.07 -24.69 63.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.841 -0.799 . . . . 1.2 109.896 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' OE1' ' NH1' ' B' ' 17' ' ' ARG . 53.5 tp10 -61.05 -36.38 79.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 1.22 109.673 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -97.76 -20.88 17.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.368 -0.832 . . . . 1.77 110.581 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -67.17 -43.56 81.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.044 -1.035 . . . . 1.25 110.858 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.48 67.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.33 111.227 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -39.46 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 117.827 -1.549 . . . . 0.44 108.471 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -65.53 -38.72 90.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.87 109.732 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.73 -40.24 87.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.835 -1.166 . . . . 1.18 109.24 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -47.94 85.1 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.744 -1.742 . . . . 0.29 108.744 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -60.87 -45.61 93.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.522 -0.987 . . . . 0.55 109.063 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.48 -47.09 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.41 109.032 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttp -60.1 -40.07 88.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.067 -1.021 . . . . 0.31 109.805 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.834 HD11 ' CE2' ' B' ' 48' ' ' PHE . 60.4 tp -65.54 -40.08 92.48 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.299 -0.876 . . . . 0.34 109.567 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.1 -39.3 94.3 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.69 -0.631 . . . . 0.38 109.948 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 47' ' ' ARG . 94.8 mt-10 -82.95 5.75 20.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 1.26 110.045 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -50.89 130.15 24.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 1.16 109.587 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.79 -19.15 58.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 1.35 110.697 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -71.22 -35.89 71.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.923 -1.11 . . . . 1.36 109.522 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.17 -39.98 74.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.545 -0.722 . . . . 0.32 110.064 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.63 -48.31 82.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.801 . . . . 1.24 109.455 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -69.91 -40.99 75.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 0.7 110.856 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.06 -40.13 75.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.036 -1.04 . . . . 1.2 111.806 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 89.5 mt -67.57 -45.72 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.183 . . . . 0.34 109.16 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.86 -39.23 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.5 110.863 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.86 84.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.983 . . . . 0.47 111.171 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.8 -45.95 92.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.864 -1.147 . . . . 0.48 109.866 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.3 mt -61.26 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.41 108.407 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -41.99 76.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.449 -0.782 . . . . 1.95 110.628 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -81.95 -50.89 8.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.856 -1.153 . . . . 1.21 112.153 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -91.62 -2.01 57.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.934 -1.104 . . . . 2.12 112.203 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.6 m170 55.16 38.89 31.14 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.025 -1.047 . . . . 1.31 109.832 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtp -93.13 169.8 10.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.902 -0.59 . . . . 1.38 109.597 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.2 p -81.01 159.83 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.143 -0.973 . . . . 0.4 109.79 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.29 83.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.42 110.707 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.53 -34.3 72.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.827 -1.171 . . . . 2.18 109.633 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 -40.46 25.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.922 -1.111 . . . . 0.42 109.48 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.32 -46.15 64.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.37 110.056 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.0 89.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.33 109.738 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.522 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.9 t60 -59.66 -40.18 86.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.72 109.892 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.84 -40.2 96.03 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 1.26 110.311 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 -54.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.887 . . . . 0.33 111.131 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.65 -40.63 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.851 -1.156 . . . . 0.44 109.223 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.98 -39.53 93.61 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.636 -0.876 . . . . 1.91 108.636 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.71 -49.38 74.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.104 -1.198 . . . . 0.42 110.104 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -67.02 -52.9 36.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.782 -1.422 . . . . 1.17 109.346 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.39 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.44 108.863 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.0 t -59.64 -40.28 87.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.296 -0.877 . . . . 1.32 108.885 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.85 95.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.173 -0.955 . . . . 0.51 109.077 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.59 -40.09 96.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 0.6 109.738 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.501 -1.374 . . . . 1.68 109.619 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.46 -20.4 12.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.139 -0.976 . . . . 1.39 108.648 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 84.5 mt -63.16 147.37 51.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.63 109.575 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.53 40.6 1.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.781 . . . . 2.35 109.897 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.302 -0.874 . . . . 1.26 110.241 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.1 -30.03 67.13 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.354 0.597 . . . . 2.54 110.443 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 4.3 t80 -71.91 -40.06 69.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.99 110.595 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 118' ' ' LEU . 80.6 mt -73.86 -34.66 64.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.096 -1.002 . . . . 0.63 108.63 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -62.04 -42.09 98.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 2.08 110.505 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 91.7 mt-10 -60.45 -44.56 95.7 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.638 -1.289 . . . . 2.33 109.861 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.565 HH21 ' CD ' ' B' ' 51' ' ' GLN . 26.8 mtp180 -59.94 -36.06 76.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.849 -1.157 . . . . 2.12 108.397 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.98 67.5 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.097 -1.075 . . . . 0.53 108.097 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.22 -40.07 74.75 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.725 -0.842 . . . . 0.56 108.725 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.42 -40.0 89.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 1.31 109.382 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.34 -40.18 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.85 -0.796 . . . . 0.39 108.85 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -60.02 -40.37 89.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.371 -0.831 . . . . 2.83 109.391 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.93 -39.57 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.598 -0.688 . . . . 1.2 110.168 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.7 -45.36 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.46 109.89 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.52 63.09 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.287 -1.125 . . . . 0.35 110.287 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -59.55 -47.78 84.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.353 -1.086 . . . . 2.48 109.557 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.527 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.7 mtp180 -69.92 -31.06 68.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 2.66 109.953 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.03 -42.12 84.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.44 108.732 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.93 -40.13 92.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.21 -0.931 . . . . 0.54 109.244 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.869 -1.133 . . . . 2.81 108.652 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.14 -38.02 87.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.54 -0.725 . . . . 1.24 111.295 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.1 -43.53 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.421 -1.424 . . . . 0.4 108.012 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.04 -32.87 69.72 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.61 109.149 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.1 42.37 7.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.009 -1.636 . . . . 0.42 109.009 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.55 148.59 40.73 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.572 -0.957 . . . . 0.63 110.647 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.09 138.74 58.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.311 0.576 . . . . 2.41 110.577 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.13 127.46 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.348 1.071 . . . . 0.56 108.204 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.23 -39.91 85.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.533 -0.758 . . . . 0.92 110.562 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.63 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 1.23 109.188 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.41 -0.8 27.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.56 110.318 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -14.92 44.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.633 -1.292 . . . . 1.41 109.964 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.22 28.46 0.45 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.006 -1.059 . . . . 0.66 111.314 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.7 mm -89.2 119.77 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.319 -1.488 . . . . 1.41 110.039 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.93 -13.04 18.48 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.277 -0.889 . . . . 2.14 110.491 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.5 151.45 48.84 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.036 -1.04 . . . . 1.29 110.712 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.12 134.02 54.09 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.538 -0.912 . . . . 1.2 108.538 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.8 165.23 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.38 110.068 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.99 146.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.427 -2.064 . . . . 0.28 105.427 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.7 tp -99.27 117.76 34.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.039 -1.038 . . . . 0.41 110.376 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.485 HG12 HG22 ' A' ' 209' ' ' THR . 59.5 t -121.06 129.86 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.777 -0.823 . . . . 0.4 108.777 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.26 160.92 39.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.38 109.253 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.21 79.95 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.28 -1.513 . . . . 0.5 107.958 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.37 146.57 2.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.729 -0.841 . . . . 2.09 108.729 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 mt -112.79 138.22 49.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.384 -0.823 . . . . 0.49 110.015 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.4 p -93.99 146.29 31.4 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.886 . . . . 0.55 108.723 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -39.8 -36.48 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.15 1.9 . . . . 0.49 112.562 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.41 ' HB3' HH12 ' A' ' 136' ' ' ARG . 75.4 m -59.75 -40.33 87.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.49 110.342 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.98 -40.72 78.64 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 1.22 110.011 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.1 p -55.45 -30.96 61.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.43 111.683 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.61 -52.84 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.798 -1.189 . . . . 0.4 110.339 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.49 36.95 0.61 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.419 -0.801 . . . . 0.59 108.971 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.66 138.88 41.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.657 -0.652 . . . . 0.64 109.472 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.94 102.27 13.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.138 -0.976 . . . . 1.85 109.586 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.6 mt -65.06 -40.66 95.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.958 . . . . 0.55 110.624 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.39 -29.78 67.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.814 -1.179 . . . . 2.03 112.018 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.2 -7.5 45.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.693 -1.254 . . . . 1.88 110.319 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.4 t -102.11 113.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.404 -1.332 . . . . 0.42 107.404 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.75 6.82 22.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.074 -1.016 . . . . 0.52 110.833 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.9 174.73 37.75 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.35 -1.5 . . . . 0.3 109.35 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.465 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 9.8 m-85 -134.42 129.39 35.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -1.02 . . . . 0.46 108.447 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.2 mt -132.04 126.24 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.766 . . . . 0.38 109.086 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.7 p -149.91 162.13 40.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.838 -1.164 . . . . 0.43 111.0 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.58 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.42 24.85 10.97 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.47 -0.567 . . . . 2.13 109.47 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.31 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.67 -1.269 . . . . 0.64 111.207 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.65 -53.25 6.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.565 -1.014 . . . . 0.69 110.565 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.45 -144.58 8.26 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.092 -1.528 . . . . 0.73 110.668 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.687 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -65.63 -25.41 67.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.032 . . . . 3.82 109.654 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 44.8 p -65.1 2.99 0.66 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.134 -0.979 . . . . 1.18 109.192 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 186' ' ' ARG . 20.5 t -92.09 131.69 37.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.351 -0.843 . . . . 1.26 110.225 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -47.95 -54.56 12.39 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.302 -0.874 . . . . 0.49 110.896 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 t -56.04 -35.25 66.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.231 -0.918 . . . . 1.63 110.8 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.12 -40.34 89.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.925 -1.109 . . . . 1.36 110.507 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.69 -38.15 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 1.36 109.144 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 97.9 mtp -60.26 -40.73 91.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.94 110.728 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.4 87.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.685 -1.259 . . . . 0.52 108.471 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -60.67 -58.23 9.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 2.94 109.46 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.3 m -63.13 -39.78 95.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.69 111.457 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.94 -23.32 62.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.824 -1.172 . . . . 0.73 109.494 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 64.68 49.33 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 1.43 110.148 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.88 143.94 46.93 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 107.774 -1.195 . . . . 0.61 107.774 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.29 137.51 79.09 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 121.857 1.705 . . . . 0.53 112.09 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.38 150.66 2.92 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.026 -1.046 . . . . 0.39 111.441 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.34 148.67 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 107.832 -1.173 . . . . 0.44 107.832 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.26 -9.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.999 -1.063 . . . . 0.5 110.261 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.99 23.57 16.44 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.914 -0.874 . . . . 0.53 110.914 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.6 p -44.55 -43.78 8.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.286 . . . . 0.59 109.965 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 182' ' ' ASP . . . 94.55 -50.82 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.368 -0.92 . . . . 0.65 111.079 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.78 40.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.624 -1.516 . . . . 1.61 111.19 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.13 -41.07 30.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 0.5 109.535 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 159' ' ' VAL . 2.6 p -56.96 -30.55 64.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.63 110.671 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 14.5 t -77.41 -13.2 59.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.827 -1.171 . . . . 1.37 109.32 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.45 -12.78 17.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.647 -0.658 . . . . 2.11 109.692 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 87.1 t -109.66 141.67 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.773 0.797 . . . . 0.87 111.273 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.4 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 105.752 -1.944 . . . . 2.13 105.752 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 51.3 p-10 -60.97 152.4 27.87 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.176 -1.577 . . . . 2.1 108.837 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER 75.16 9.88 3.78 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 120.784 0.326 . . . . 2.28 110.811 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.89 143.42 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 1.96 107.955 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -91.75 122.05 33.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.837 -1.172 . . . . 0.45 107.837 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 77.7 mt -129.92 147.89 51.73 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.49 110.419 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.89 126.06 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.235 -1.765 . . . . 0.43 106.235 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.3 tp -98.67 118.1 34.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.53 109.43 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.7 m-20 -75.79 -45.15 37.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.296 -0.878 . . . . 2.2 108.735 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.8 14.44 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.653 -0.869 . . . . 0.44 108.653 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.473 ' N ' ' C ' ' A' ' 221' ' ' ASP . 73.6 t -129.58 -46.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.172 -1.418 . . . . 0.54 107.172 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -97.41 0.89 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.478 -1.675 . . . . 2.02 106.478 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.61 10.7 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.857 -0.611 . . . . 1.41 109.584 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.02 155.52 50.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.431 -0.793 . . . . 1.48 109.754 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.17 130.05 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.441 -0.948 . . . . 0.52 108.441 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.76 122.77 45.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.7 109.549 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.98 113.84 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.693 . . . . 0.52 110.602 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 54.17 67.08 3.71 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.128 -0.982 . . . . 1.41 110.772 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.19 144.39 4.95 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.864 2.376 . . . . 0.85 112.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.57 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 1.47 109.428 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.71 86.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 2.35 109.788 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.97 -36.8 77.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 2.78 109.584 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.47 -40.43 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.018 . . . . 0.88 109.317 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.69 -45.75 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.78 109.068 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -45.16 75.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.275 -1.009 . . . . 2.12 108.275 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.57 -40.35 96.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 2.23 109.001 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.1 mtp -69.9 -31.55 69.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.338 -0.851 . . . . 0.85 109.967 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.48 -39.96 81.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 2.69 109.972 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.46 89.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 1.02 108.699 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.66 -40.06 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.07 109.342 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.37 -39.83 88.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 1.81 108.711 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.65 -39.92 90.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 1.78 108.946 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.1 -43.13 99.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.95 . . . . 2.36 108.523 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.54 96.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.489 -0.757 . . . . 1.7 109.634 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.67 95.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 2.14 108.993 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.8 t -63.52 -39.98 95.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 2.62 109.0 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 3.24 109.614 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.09 -0.707 . . . . 1.69 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -152.6 151.03 30.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.197 -0.939 . . . . 0.74 109.385 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -149.98 159.95 44.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 1.89 110.809 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -153.8 150.46 28.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.618 -0.676 . . . . 2.01 109.608 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.49 131.13 55.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.289 -0.882 . . . . 2.12 110.137 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.88 121.92 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 122.266 1.031 . . . . 0.45 112.392 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.45 ' OG1' HG22 ' B' ' 60' ' ' VAL . 74.1 m -77.85 105.24 8.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.832 0.825 . . . . 0.52 110.545 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.04 122.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.447 1.118 . . . . 0.46 110.628 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' THR . . . . . 0.433 HG23 ' O ' ' B' ' 7' ' ' THR . 67.3 p -109.16 19.98 18.86 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.198 -0.91 . . . . 0.58 110.231 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.86 116.58 56.77 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.202 -1.036 . . . . 0.57 108.202 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.14 -13.38 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.173 1.097 . . . . 0.98 113.208 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -119.91 11.24 11.76 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.454 -0.779 . . . . 1.41 109.297 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 177.26 34.2 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.758 -1.737 . . . . 0.47 108.758 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LEU . . . . . 0.512 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.2 tp -83.72 88.02 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.076 -1.249 . . . . 0.43 108.098 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' B' ' 17' ' ' ARG . 4.1 p80 -90.43 -162.59 0.91 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.831 -1.168 . . . . 0.37 110.536 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -41.7 82.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.121 -0.987 . . . . 0.42 112.215 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' B' ' 17' ' ' ARG . 1.8 tpt180 -60.15 -59.97 12.13 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.517 -1.364 . . . . 1.55 111.715 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.59 -32.48 87.62 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 120.339 1.157 . . . . 0.35 112.213 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.83 72.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.018 . . . . 0.35 108.445 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.46 64.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.906 -0.718 . . . . 0.3 109.272 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.3 -39.97 64.89 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.215 -0.994 . . . . 2.28 108.5 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -60.65 -50.71 72.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.51 110.041 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 44' ' ' ALA . 66.4 t -67.89 -28.91 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.902 -1.124 . . . . 0.31 109.731 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -60.31 -45.77 92.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 1.23 109.691 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.64 -47.77 79.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 1.89 110.245 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.56 56.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.112 -0.992 . . . . 0.48 111.55 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.01 -12.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.761 -1.212 . . . . 1.14 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.2 -22.54 73.39 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.69 109.14 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -106.05 142.74 35.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.469 -1.018 . . . . 0.77 109.093 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.4 -11.53 37.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 1.5 109.491 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' B' ' 69' ' ' ASP . 30.2 p -63.28 152.76 36.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 1.36 109.817 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.25 131.94 45.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.516 -0.92 . . . . 2.43 108.516 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.94 131.13 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.409 -0.807 . . . . 0.44 109.096 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.5 m -128.07 147.7 50.54 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.102 -0.703 . . . . 0.45 109.102 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.78 140.93 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.003 -1.851 . . . . 0.62 106.003 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -130.56 122.76 28.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.48 109.506 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 6.9 p -137.81 122.22 18.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.24 110.317 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 39.77 64.33 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.652 . . . . 2.22 112.087 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.09 -10.07 4.83 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.464 -1.397 . . . . 0.61 113.565 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -112.39 123.98 51.49 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.469 1.634 . . . . 2.28 109.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.51 145.0 48.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.375 -0.828 . . . . 1.21 109.734 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.0 164.64 29.73 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.607 0.717 . . . . 0.37 110.502 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 131.47 34.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.713 -0.617 . . . . 1.18 109.825 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.531 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -71.51 -16.27 62.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.983 -1.073 . . . . 0.3 110.004 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -90.05 21.3 3.76 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.583 -1.636 . . . . 2.49 106.583 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -145.09 92.22 2.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.867 0.842 . . . . 1.35 111.424 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.71 ' HB3' HD13 ' A' ' 79' ' ' LEU . 54.2 tp -60.1 -35.94 76.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.003 -0.74 . . . . 0.41 109.003 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.834 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 -55.55 -51.57 66.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.369 -0.832 . . . . 0.35 110.008 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -70.29 -40.04 74.52 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.002 -1.061 . . . . 1.3 109.909 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' B' ' 52' ' ' THR . 48.6 mt -50.28 -53.12 30.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.53 -1.356 . . . . 0.4 108.988 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLN . . . . . 0.565 ' CD ' HH21 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -41.93 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.217 -0.927 . . . . 2.24 110.653 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 52' ' ' THR . . . . . 0.538 ' N ' ' O ' ' B' ' 50' ' ' LEU . 67.0 p -84.53 -9.9 57.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.466 -1.396 . . . . 0.4 110.449 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.2 mt -94.75 117.46 30.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.892 -1.13 . . . . 0.36 109.223 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.81 91.92 0.8 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.475 -1.85 . . . . 0.42 108.475 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 mt -100.25 93.03 5.48 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.153 -1.204 . . . . 0.46 109.578 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -93.92 178.41 5.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.061 -1.025 . . . . 0.56 111.163 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.43 113.67 6.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.551 -0.718 . . . . 1.88 110.262 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.04 9.06 43.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.492 -1.443 . . . . 0.59 109.492 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 34.4 m -86.35 109.59 19.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -1.154 . . . . 0.53 110.491 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' B' ' 7' ' ' THR . 44.0 t -77.25 115.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.252 1.025 . . . . 0.49 109.046 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.0 m -110.15 176.57 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.827 -1.175 . . . . 0.38 107.827 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -131.61 129.82 41.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.895 -1.15 . . . . 0.43 107.895 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -103.51 118.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.843 -1.54 . . . . 0.39 106.843 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -119.74 132.54 55.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.835 -0.802 . . . . 1.31 108.835 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.13 151.46 38.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.5 109.866 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.45 124.14 12.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.6 -0.889 . . . . 2.09 108.6 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.47 -160.24 31.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.468 -1.349 . . . . 0.66 110.711 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.17 -49.94 75.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.165 -0.609 . . . . 2.15 112.329 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' B' ' 31' ' ' SER . 82.5 m-20 -106.92 11.01 30.39 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.786 -1.196 . . . . 1.51 111.566 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -40.67 -34.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 2.17 111.909 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.83 -42.3 73.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.682 -1.262 . . . . 2.41 110.613 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -68.91 -52.07 33.25 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.985 -1.072 . . . . 2.57 108.883 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.93 -36.44 7.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.594 -0.691 . . . . 0.73 111.555 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.556 ' O ' HG23 ' B' ' 78' ' ' VAL . 99.7 t -80.74 -37.73 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.391 -1.443 . . . . 0.56 109.984 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.19 -38.15 78.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.761 -1.212 . . . . 2.19 110.917 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -82.3 -47.04 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.52 -1.362 . . . . 1.37 110.622 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.84 -37.72 80.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.734 -1.229 . . . . 0.5 109.229 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 74' ' ' VAL . 47.6 t -62.48 -43.93 98.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.224 -0.922 . . . . 0.55 109.22 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' B' ' 83' ' ' GLU . 93.5 mttt -70.24 -56.14 7.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 2.16 107.89 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 tp -54.01 -31.76 52.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.61 109.328 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.5 ttm -74.25 -38.42 63.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.66 -1.275 . . . . 1.52 108.256 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.55 -5.39 57.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.297 -0.877 . . . . 0.75 110.134 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 79' ' ' LYS . 2.9 mm-40 -110.24 -2.26 16.89 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.985 -1.072 . . . . 2.17 111.631 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 mt -83.28 129.98 35.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.379 -1.451 . . . . 1.05 109.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 117.941 -1.028 . . . . 2.44 109.523 -179.314 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmm . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.366 -0.605 . . . . 3.09 109.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 72.6 mt -107.94 129.92 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 108.949 -0.76 . . . . 1.03 108.949 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.2 m -129.96 141.77 50.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.203 -0.936 . . . . 0.7 110.451 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -123.41 -159.58 10.55 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 108.334 -1.907 . . . . 0.52 108.334 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 5' ' ' ILE . 81.8 mt -94.99 -12.07 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 120.759 -1.436 . . . . 0.69 111.041 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.1 tp 53.36 103.92 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.14 -0.975 . . . . 0.57 109.579 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.58 -25.49 16.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.274 -0.891 . . . . 0.72 109.821 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 2.6 m -141.78 126.4 10.35 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.222 -0.924 . . . . 1.35 108.87 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.12 142.81 15.56 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 122.005 1.803 . . . . 0.6 111.774 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.756 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.35 -160.85 33.53 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.665 -1.774 . . . . 0.51 108.665 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.3 mt -149.52 150.14 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.088 -1.242 . . . . 0.59 108.252 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.18 154.68 31.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.782 -1.199 . . . . 0.38 111.185 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.0 m-85 -133.78 126.81 31.42 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.145 -1.057 . . . . 0.57 108.145 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.86 178.67 48.67 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.678 -1.725 . . . . 0.36 110.921 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -79.75 159.97 26.39 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.756 -0.849 . . . . 1.8 109.224 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.8 129.06 53.14 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.317 -0.864 . . . . 0.4 111.106 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -100.93 134.69 43.53 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.806 -1.183 . . . . 0.46 107.806 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.1 tp -116.92 122.41 44.24 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.46 110.542 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.74 103.44 15.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.631 -0.668 . . . . 0.53 110.266 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.0 mttt -98.41 134.93 40.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.412 -0.805 . . . . 2.01 109.249 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -130.78 130.54 43.85 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.124 -0.985 . . . . 2.32 109.381 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -75.91 147.41 38.99 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.878 -1.138 . . . . 2.07 109.375 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.25 140.19 57.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 2.09 109.341 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.2 mt -79.31 130.19 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.456 -0.777 . . . . 0.54 109.522 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 t -97.04 126.45 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.294 -0.879 . . . . 0.6 109.748 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.1 mt -105.78 136.87 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.818 -0.808 . . . . 0.49 108.818 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.04 121.22 33.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.098 -1.001 . . . . 1.23 109.95 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -88.58 -3.23 58.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.899 . . . . 2.6 108.94 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -63.31 139.57 58.78 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 1.83 109.174 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -86.23 150.03 24.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.919 . . . . 2.18 109.1 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.468 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -95.18 165.04 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.44 110.301 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 75.3 p -96.24 173.11 7.56 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.379 -0.971 . . . . 0.54 108.379 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.25 78.41 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.107 -0.995 . . . . 0.6 109.541 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -54.46 -29.99 51.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.784 -1.197 . . . . 2.18 109.176 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -82.79 -10.35 58.91 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.87 110.728 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.4 t -63.88 -52.76 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.613 -1.304 . . . . 0.43 108.677 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -60.29 -40.13 89.38 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.293 -0.879 . . . . 1.23 110.103 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -68.66 -40.02 80.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.014 -1.054 . . . . 2.12 110.793 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.468 ' HG3' HG21 ' A' ' 31' ' ' ILE . 60.1 mm-40 -65.31 -40.15 93.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.746 -1.221 . . . . 1.24 110.031 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.36 -46.79 94.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 120.791 -1.193 . . . . 0.5 108.558 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.03 -41.34 92.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.868 . . . . 1.32 109.491 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -60.13 -44.18 95.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.999 -1.063 . . . . 2.94 108.187 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 65.7 t80 -60.75 -49.82 75.95 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.834 -0.802 . . . . 0.68 108.834 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.7 tp -61.43 -44.36 97.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.377 -0.827 . . . . 0.72 108.81 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -64.48 -43.77 93.1 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.958 -1.089 . . . . 0.7 109.228 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.96 -40.21 84.5 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.729 -1.748 . . . . 0.46 108.729 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 47' ' ' ARG . 37.0 ttt-85 -65.54 -31.93 73.26 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.251 -1.018 . . . . 2.82 108.251 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.84 -41.08 90.6 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.922 -0.77 . . . . 0.72 108.922 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.6 ttpt -63.8 -73.01 0.12 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.881 -1.137 . . . . 1.87 108.186 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.5 -33.72 0.11 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.316 -0.865 . . . . 0.39 111.202 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.3 t -58.56 -56.06 27.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.658 -1.276 . . . . 1.46 108.144 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.97 76.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.535 -0.728 . . . . 0.44 111.391 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.35 -40.17 85.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.688 -1.257 . . . . 1.27 110.214 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.1 mt -62.14 -40.22 95.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.804 -1.185 . . . . 0.46 108.845 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -61.25 -38.07 85.36 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.491 -0.756 . . . . 1.17 109.835 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.8 m -63.0 -41.41 99.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.062 -1.024 . . . . 0.41 109.23 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.527 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.6 mt -62.72 -38.74 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.89 . . . . 0.42 109.511 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -56.96 -51.32 69.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 0.96 109.818 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.42 -33.99 70.28 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.359 -0.838 . . . . 0.51 110.462 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -69.63 -37.48 76.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.851 -1.155 . . . . 1.63 109.345 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.85 90.46 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.468 -0.77 . . . . 0.35 109.572 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.26 -51.35 59.37 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 110.504 -1.038 . . . . 0.37 110.504 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.95 -45.2 67.96 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.094 -1.239 . . . . 1.18 109.754 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.5 m -65.78 -63.16 1.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.328 -0.858 . . . . 0.39 112.031 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.51 -48.66 5.46 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.031 -1.043 . . . . 0.43 111.66 -177.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.06 -168.74 25.59 Favored Glycine 0 N--CA 1.503 3.16 0 C-N-CA 119.575 -1.298 . . . . 0.36 111.404 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -70.07 -24.69 63.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.841 -0.799 . . . . 1.2 109.896 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.444 ' OE1' ' NH1' ' B' ' 17' ' ' ARG . 53.5 tp10 -61.05 -36.38 79.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.309 -0.869 . . . . 1.22 109.673 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -97.76 -20.88 17.28 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.368 -0.832 . . . . 1.77 110.581 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -67.17 -43.56 81.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.044 -1.035 . . . . 1.25 110.858 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.16 -28.48 67.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.33 111.227 -177.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.8 mt -59.24 -39.46 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 117.827 -1.549 . . . . 0.44 108.471 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -65.53 -38.72 90.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.107 -0.996 . . . . 0.87 109.732 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -59.73 -40.24 87.41 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.835 -1.166 . . . . 1.18 109.24 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.75 -47.94 85.1 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.744 -1.742 . . . . 0.29 108.744 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -60.87 -45.61 93.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.522 -0.987 . . . . 0.55 109.063 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 92.1 mt -66.48 -47.09 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.33 -0.856 . . . . 0.41 109.032 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.2 ttp -60.1 -40.07 88.36 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.067 -1.021 . . . . 0.31 109.805 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.834 HD11 ' CE2' ' B' ' 48' ' ' PHE . 60.4 tp -65.54 -40.08 92.48 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.299 -0.876 . . . . 0.34 109.567 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.0 tp -63.1 -39.3 94.3 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.69 -0.631 . . . . 0.38 109.948 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HG2' HH21 ' A' ' 47' ' ' ARG . 94.8 mt-10 -82.95 5.75 20.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.283 -0.886 . . . . 1.26 110.045 -179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -50.89 130.15 24.68 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.937 -1.102 . . . . 1.16 109.587 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -60.79 -19.15 58.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.383 -0.823 . . . . 1.35 110.697 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -71.22 -35.89 71.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.923 -1.11 . . . . 1.36 109.522 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.17 -39.98 74.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.545 -0.722 . . . . 0.32 110.064 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -60.63 -48.31 82.37 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.801 . . . . 1.24 109.455 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -69.91 -40.99 75.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.333 -0.854 . . . . 0.7 110.856 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -70.06 -40.13 75.25 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.036 -1.04 . . . . 1.2 111.806 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.42 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 89.5 mt -67.57 -45.72 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.808 -1.183 . . . . 0.34 109.16 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 66.4 mt -67.86 -39.23 81.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.673 -0.642 . . . . 0.5 110.863 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.19 -47.86 84.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.126 -0.983 . . . . 0.47 111.171 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.7 mt -60.8 -45.95 92.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.864 -1.147 . . . . 0.48 109.866 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.3 mt -61.26 -49.14 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.082 -1.011 . . . . 0.41 108.407 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.2 mttt -69.31 -41.99 76.01 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.449 -0.782 . . . . 1.95 110.628 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -81.95 -50.89 8.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.856 -1.153 . . . . 1.21 112.153 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 mttp -91.62 -2.01 57.25 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.934 -1.104 . . . . 2.12 112.203 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.6 m170 55.16 38.89 31.14 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.025 -1.047 . . . . 1.31 109.832 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 mtp -93.13 169.8 10.13 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 115.902 -0.59 . . . . 1.38 109.597 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.2 p -81.01 159.83 24.74 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.143 -0.973 . . . . 0.4 109.79 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.01 -40.29 83.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.42 110.707 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 101' ' ' ASP . 3.2 p-10 -70.53 -34.3 72.13 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.827 -1.171 . . . . 2.18 109.633 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.57 -40.46 25.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.922 -1.111 . . . . 0.42 109.48 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.32 -46.15 64.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.37 110.056 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.0 89.1 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.192 -0.942 . . . . 0.33 109.738 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.522 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 80.9 t60 -59.66 -40.18 86.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.72 109.892 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.84 -40.2 96.03 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.331 -0.856 . . . . 1.26 110.311 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.64 -54.46 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.887 . . . . 0.33 111.131 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.6 mm -68.65 -40.63 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.851 -1.156 . . . . 0.44 109.223 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.522 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.98 -39.53 93.61 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.636 -0.876 . . . . 1.91 108.636 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -57.71 -49.38 74.55 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.104 -1.198 . . . . 0.42 110.104 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -67.02 -52.9 36.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.782 -1.422 . . . . 1.17 109.346 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.39 70.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -0.929 . . . . 0.44 108.863 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 43.0 t -59.64 -40.28 87.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.296 -0.877 . . . . 1.32 108.885 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.79 -39.85 95.24 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.173 -0.955 . . . . 0.51 109.077 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.1 mt -63.59 -40.09 96.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.316 -0.865 . . . . 0.6 109.738 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.91 -35.32 74.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.501 -1.374 . . . . 1.68 109.619 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.46 -20.4 12.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.139 -0.976 . . . . 1.39 108.648 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 84.5 mt -63.16 147.37 51.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.63 109.575 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -98.53 40.6 1.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.451 -0.781 . . . . 2.35 109.897 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -131.57 133.87 45.47 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.302 -0.874 . . . . 1.26 110.241 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.1 -30.03 67.13 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.354 0.597 . . . . 2.54 110.443 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.56 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 4.3 t80 -71.91 -40.06 69.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.452 -0.78 . . . . 0.99 110.595 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 118' ' ' LEU . 80.6 mt -73.86 -34.66 64.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.096 -1.002 . . . . 0.63 108.63 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 49.4 tttt -62.04 -42.09 98.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 2.08 110.505 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 91.7 mt-10 -60.45 -44.56 95.7 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.638 -1.289 . . . . 2.33 109.861 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.565 HH21 ' CD ' ' B' ' 51' ' ' GLN . 26.8 mtp180 -59.94 -36.06 76.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.849 -1.157 . . . . 2.12 108.397 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.32 -25.98 67.5 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.097 -1.075 . . . . 0.53 108.097 178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.22 -40.07 74.75 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.725 -0.842 . . . . 0.56 108.725 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.42 -40.0 89.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 1.31 109.382 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.0 t -68.34 -40.18 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.85 -0.796 . . . . 0.39 108.85 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -60.02 -40.37 89.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.371 -0.831 . . . . 2.83 109.391 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.93 -39.57 85.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.598 -0.688 . . . . 1.2 110.168 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.7 -45.36 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.07 -1.019 . . . . 0.46 109.89 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.52 63.09 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.287 -1.125 . . . . 0.35 110.287 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -59.55 -47.78 84.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.353 -1.086 . . . . 2.48 109.557 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.527 HH22 ' CD1' ' A' ' 57' ' ' ILE . 65.7 mtp180 -69.92 -31.06 68.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.975 -1.078 . . . . 2.66 109.953 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.4 tp -58.03 -42.12 84.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.246 -0.909 . . . . 0.44 108.732 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.93 -40.13 92.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.21 -0.931 . . . . 0.54 109.244 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.869 -1.133 . . . . 2.81 108.652 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -62.14 -38.02 87.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.54 -0.725 . . . . 1.24 111.295 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.1 -43.53 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 120.421 -1.424 . . . . 0.4 108.012 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -71.04 -32.87 69.72 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.409 -0.807 . . . . 0.61 109.149 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.1 42.37 7.6 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.009 -1.636 . . . . 0.42 109.009 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 8.4 tp -74.55 148.59 40.73 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.572 -0.957 . . . . 0.63 110.647 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -61.09 138.74 58.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.311 0.576 . . . . 2.41 110.577 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 84.4 mt -117.13 127.46 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 CA-C-O 122.348 1.071 . . . . 0.56 108.204 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.2 mt -66.23 -39.91 85.53 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.533 -0.758 . . . . 0.92 110.562 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.7 t0 61.63 113.62 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.326 -0.859 . . . . 1.23 109.188 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.41 -0.8 27.18 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.56 110.318 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -14.92 44.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.633 -1.292 . . . . 1.41 109.964 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.22 28.46 0.45 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.006 -1.059 . . . . 0.66 111.314 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 46.7 mm -89.2 119.77 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.319 -1.488 . . . . 1.41 110.039 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -100.93 -13.04 18.48 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.277 -0.889 . . . . 2.14 110.491 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -127.5 151.45 48.84 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.036 -1.04 . . . . 1.29 110.712 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -64.12 134.02 54.09 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.538 -0.912 . . . . 1.2 108.538 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.6 m -151.8 165.23 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.463 -0.773 . . . . 0.38 110.068 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.4 mt -93.99 146.86 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 105.427 -2.064 . . . . 0.28 105.427 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 62.7 tp -99.27 117.76 34.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.039 -1.038 . . . . 0.41 110.376 -177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.485 HG12 HG22 ' A' ' 209' ' ' THR . 59.5 t -121.06 129.86 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 N-CA-C 108.777 -0.823 . . . . 0.4 108.777 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.26 160.92 39.11 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.033 -1.042 . . . . 0.38 109.253 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -68.47 -37.21 79.95 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.28 -1.513 . . . . 0.5 107.958 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -170.37 146.57 2.88 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.729 -0.841 . . . . 2.09 108.729 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 26.0 mt -112.79 138.22 49.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.384 -0.823 . . . . 0.49 110.015 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 45.4 p -93.99 146.29 31.4 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.283 -0.886 . . . . 0.55 108.723 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -39.8 -36.48 1.27 Allowed 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.15 1.9 . . . . 0.49 112.562 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.41 ' HB3' HH12 ' A' ' 136' ' ' ARG . 75.4 m -59.75 -40.33 87.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.49 110.342 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -68.98 -40.72 78.64 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 120.987 -1.07 . . . . 1.22 110.011 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.1 p -55.45 -30.96 61.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.308 -0.87 . . . . 0.43 111.683 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.61 -52.84 12.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.798 -1.189 . . . . 0.4 110.339 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -84.49 36.95 0.61 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.419 -0.801 . . . . 0.59 108.971 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 22.5 tp -105.66 138.88 41.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.657 -0.652 . . . . 0.64 109.472 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -84.94 102.27 13.02 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.138 -0.976 . . . . 1.85 109.586 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.6 mt -65.06 -40.66 95.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.958 . . . . 0.55 110.624 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -69.39 -29.78 67.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.814 -1.179 . . . . 2.03 112.018 -177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -93.2 -7.5 45.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.693 -1.254 . . . . 1.88 110.319 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 79.4 t -102.11 113.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 107.404 -1.332 . . . . 0.42 107.404 177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.6 mt -84.75 6.82 22.84 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.074 -1.016 . . . . 0.52 110.833 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.9 174.73 37.75 Favored Glycine 0 N--CA 1.485 1.907 0 N-CA-C 109.35 -1.5 . . . . 0.3 109.35 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.465 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 9.8 m-85 -134.42 129.39 35.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.465 -1.02 . . . . 0.46 108.447 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 92.2 mt -132.04 126.24 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.475 -0.766 . . . . 0.38 109.086 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.7 p -149.91 162.13 40.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.838 -1.164 . . . . 0.43 111.0 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.58 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.0 OUTLIER -104.42 24.85 10.97 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.47 -0.567 . . . . 2.13 109.47 -179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.31 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.67 -1.269 . . . . 0.64 111.207 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.65 -53.25 6.63 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.565 -1.014 . . . . 0.69 110.565 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.45 -144.58 8.26 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.092 -1.528 . . . . 0.73 110.668 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.687 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -65.63 -25.41 67.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -1.032 . . . . 3.82 109.654 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 44.8 p -65.1 2.99 0.66 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.134 -0.979 . . . . 1.18 109.192 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.486 ' H ' ' C ' ' A' ' 186' ' ' ARG . 20.5 t -92.09 131.69 37.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.351 -0.843 . . . . 1.26 110.225 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -47.95 -54.56 12.39 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.302 -0.874 . . . . 0.49 110.896 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.2 t -56.04 -35.25 66.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.231 -0.918 . . . . 1.63 110.8 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.12 -40.34 89.39 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.925 -1.109 . . . . 1.36 110.507 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.69 -38.15 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.091 -1.005 . . . . 1.36 109.144 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 97.9 mtp -60.26 -40.73 91.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.94 110.728 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.4 87.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.685 -1.259 . . . . 0.52 108.471 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -60.67 -58.23 9.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.447 -0.783 . . . . 2.94 109.46 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.3 m -63.13 -39.78 95.67 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.344 -0.848 . . . . 0.69 111.457 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.94 -23.32 62.22 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.824 -1.172 . . . . 0.73 109.494 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 64.68 49.33 2.32 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.372 0.606 . . . . 1.43 110.148 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.422 ' O ' ' CB ' ' A' ' 8' ' ' SER . 85.3 mt -125.88 143.94 46.93 Favored Pre-proline 0 N--CA 1.5 2.044 0 N-CA-C 107.774 -1.195 . . . . 0.61 107.774 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -59.29 137.51 79.09 Favored 'Trans proline' 0 N--CA 1.5 1.91 0 C-N-CA 121.857 1.705 . . . . 0.53 112.09 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.38 150.66 2.92 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.026 -1.046 . . . . 0.39 111.441 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 73.3 mt -122.34 148.67 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 107.832 -1.173 . . . . 0.44 107.832 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -129.26 -9.96 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.999 -1.063 . . . . 0.5 110.261 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.99 23.57 16.44 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.914 -0.874 . . . . 0.53 110.914 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.6 p -44.55 -43.78 8.27 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.013 -1.286 . . . . 0.59 109.965 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.461 ' H ' ' HB3' ' A' ' 182' ' ' ASP . . . 94.55 -50.82 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.368 -0.92 . . . . 0.65 111.079 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 28.1 t -160.78 40.56 0.16 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.624 -1.516 . . . . 1.61 111.19 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.1 t -77.13 -41.07 30.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.908 -1.12 . . . . 0.5 109.535 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.485 HG22 HG12 ' A' ' 159' ' ' VAL . 2.6 p -56.96 -30.55 64.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.158 -0.964 . . . . 0.63 110.671 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 14.5 t -77.41 -13.2 59.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.827 -1.171 . . . . 1.37 109.32 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -102.45 -12.78 17.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.647 -0.658 . . . . 2.11 109.692 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 87.1 t -109.66 141.67 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 121.773 0.797 . . . . 0.87 111.273 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 156.31 21.4 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 105.752 -1.944 . . . . 2.13 105.752 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 51.3 p-10 -60.97 152.4 27.87 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 120.176 -1.577 . . . . 2.1 108.837 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 214' ' ' ASN . 0.5 OUTLIER 75.16 9.88 3.78 Favored 'General case' 0 N--CA 1.504 2.262 0 CA-C-O 120.784 0.326 . . . . 2.28 110.811 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.89 143.42 34.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.869 -1.144 . . . . 1.96 107.955 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -91.75 122.05 33.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.837 -1.172 . . . . 0.45 107.837 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 77.7 mt -129.92 147.89 51.73 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.323 -0.86 . . . . 0.49 110.419 -178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.8 mt -116.89 126.06 74.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.235 -1.765 . . . . 0.43 106.235 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 25.3 tp -98.67 118.1 34.62 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.077 -1.015 . . . . 0.53 109.43 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.7 m-20 -75.79 -45.15 37.73 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.296 -0.878 . . . . 2.2 108.735 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.8 14.44 0.12 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.653 -0.869 . . . . 0.44 108.653 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.473 ' N ' ' C ' ' A' ' 221' ' ' ASP . 73.6 t -129.58 -46.92 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.172 -1.418 . . . . 0.54 107.172 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -97.41 0.89 48.56 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.478 -1.675 . . . . 2.02 106.478 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 60.01 46.61 10.7 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.857 -0.611 . . . . 1.41 109.584 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -135.02 155.52 50.63 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.431 -0.793 . . . . 1.48 109.754 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 93.3 t -124.17 130.05 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 108.441 -0.948 . . . . 0.52 108.441 178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -102.76 122.77 45.16 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.436 -0.79 . . . . 0.7 109.549 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.0 t -100.98 113.84 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.591 -0.693 . . . . 0.52 110.602 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 54.17 67.08 3.71 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.128 -0.982 . . . . 1.41 110.772 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -89.19 144.39 4.95 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.864 2.376 . . . . 0.85 112.374 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.96 165.57 17.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 1.47 109.428 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -60.06 -39.71 86.98 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.38 -0.825 . . . . 2.35 109.788 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -59.97 -36.8 77.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 2.78 109.584 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.47 -40.43 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.018 . . . . 0.88 109.317 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.69 -45.75 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.78 109.068 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.99 -45.16 75.0 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.275 -1.009 . . . . 2.12 108.275 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 20.0 tttt -62.57 -40.35 96.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.48 -0.763 . . . . 2.23 109.001 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 79.1 mtp -69.9 -31.55 69.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.338 -0.851 . . . . 0.85 109.967 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 5.3 mmt180 -68.48 -39.96 81.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.1 -1.0 . . . . 2.69 109.972 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.46 89.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.169 -0.957 . . . . 1.02 108.699 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.8 t -65.66 -40.06 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.07 109.342 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -60.37 -39.83 88.64 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.159 -0.963 . . . . 1.81 108.711 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -60.65 -39.92 90.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 1.78 108.946 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -61.1 -43.13 99.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.95 . . . . 2.36 108.523 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 93.9 t -61.05 -43.54 96.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.489 -0.757 . . . . 1.7 109.634 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.67 95.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.86 . . . . 2.14 108.993 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 10.8 t -63.52 -39.98 95.86 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.0 -0.741 . . . . 2.62 109.0 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 3.24 109.614 -179.594 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ttp . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.09 -0.707 . . . . 1.69 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -152.6 151.03 30.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.197 -0.939 . . . . 0.74 109.385 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -149.98 159.95 44.0 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.953 -1.092 . . . . 1.89 110.809 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -153.8 150.46 28.48 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.618 -0.676 . . . . 2.01 109.608 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.49 131.13 55.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.289 -0.882 . . . . 2.12 110.137 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.88 121.92 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.457 0 CA-C-O 122.266 1.031 . . . . 0.45 112.392 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.45 ' OG1' HG22 ' B' ' 60' ' ' VAL . 74.1 m -77.85 105.24 8.91 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.832 0.825 . . . . 0.52 110.545 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -53.04 122.13 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 122.447 1.118 . . . . 0.46 110.628 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' THR . . . . . 0.433 HG23 ' O ' ' B' ' 7' ' ' THR . 67.3 p -109.16 19.98 18.86 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 115.198 -0.91 . . . . 0.58 110.231 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.86 116.58 56.77 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.202 -1.036 . . . . 0.57 108.202 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.14 -13.38 6.71 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 CA-C-N 120.173 1.097 . . . . 0.98 113.208 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -119.91 11.24 11.76 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.454 -0.779 . . . . 1.41 109.297 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . 73.49 177.26 34.2 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.758 -1.737 . . . . 0.47 108.758 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LEU . . . . . 0.512 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.2 tp -83.72 88.02 7.07 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.076 -1.249 . . . . 0.43 108.098 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' HIS . . . . . 0.401 ' NE2' ' HB3' ' B' ' 17' ' ' ARG . 4.1 p80 -90.43 -162.59 0.91 Allowed 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.831 -1.168 . . . . 0.37 110.536 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 17.5 m -57.74 -41.7 82.42 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.121 -0.987 . . . . 0.42 112.215 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' B' ' 17' ' ' ARG . 1.8 tpt180 -60.15 -59.97 12.13 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 120.517 -1.364 . . . . 1.55 111.715 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -61.59 -32.48 87.62 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 CA-C-N 120.339 1.157 . . . . 0.35 112.213 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -50.83 72.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.072 -1.018 . . . . 0.35 108.445 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.78 -41.46 64.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.906 -0.718 . . . . 0.3 109.272 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -73.3 -39.97 64.89 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.215 -0.994 . . . . 2.28 108.5 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -60.65 -50.71 72.42 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.441 -0.787 . . . . 0.51 110.041 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.531 HG13 ' O ' ' B' ' 44' ' ' ALA . 66.4 t -67.89 -28.91 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.902 -1.124 . . . . 0.31 109.731 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -60.31 -45.77 92.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.255 -0.903 . . . . 1.23 109.691 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -63.64 -47.77 79.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.31 -0.869 . . . . 1.89 110.245 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.56 56.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.112 -0.992 . . . . 0.48 111.55 -178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -54.01 -12.97 0.66 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.761 -1.212 . . . . 1.14 109.642 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . . . . . . . . . . . -76.2 -22.54 73.39 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.14 -1.584 . . . . 0.69 109.14 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -106.05 142.74 35.24 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.469 -1.018 . . . . 0.77 109.093 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.4 -11.53 37.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.937 -1.102 . . . . 1.5 109.491 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . 0.429 ' HB3' ' H ' ' B' ' 69' ' ' ASP . 30.2 p -63.28 152.76 36.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.915 . . . . 1.36 109.817 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -69.25 131.94 45.69 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.516 -0.92 . . . . 2.43 108.516 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 71.0 mt -129.94 131.13 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.409 -0.807 . . . . 0.44 109.096 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' THR . . . . . . . . . . . . . 19.5 m -128.07 147.7 50.54 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.102 -0.703 . . . . 0.45 109.102 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 58.8 t -114.78 140.93 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.003 -1.851 . . . . 0.62 106.003 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' THR . . . . . . . . . . . . . 89.9 m -130.56 122.76 28.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 0.48 109.506 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 6.9 p -137.81 122.22 18.32 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.401 -0.812 . . . . 1.24 110.317 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 39.77 64.33 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.658 -0.652 . . . . 2.22 112.087 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.09 -10.07 4.83 Favored Glycine 0 N--CA 1.498 2.78 0 O-C-N 120.464 -1.397 . . . . 0.61 113.565 175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -112.39 123.98 51.49 Favored 'General case' 0 N--CA 1.507 2.389 0 CA-C-N 119.469 1.634 . . . . 2.28 109.891 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.51 145.0 48.39 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.375 -0.828 . . . . 1.21 109.734 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.0 164.64 29.73 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.607 0.717 . . . . 0.37 110.502 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 131.47 34.33 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.713 -0.617 . . . . 1.18 109.825 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.531 ' O ' HG13 ' B' ' 23' ' ' VAL . . . -71.51 -16.27 62.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.983 -1.073 . . . . 0.3 110.004 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 9.6 ptmm? -90.05 21.3 3.76 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.583 -1.636 . . . . 2.49 106.583 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' SER . . . . . . . . . . . . . 29.1 m -145.09 92.22 2.24 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.867 0.842 . . . . 1.35 111.424 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.71 ' HB3' HD13 ' A' ' 79' ' ' LEU . 54.2 tp -60.1 -35.94 76.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.003 -0.74 . . . . 0.41 109.003 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.834 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.8 m-85 -55.55 -51.57 66.62 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.369 -0.832 . . . . 0.35 110.008 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mtmm -70.29 -40.04 74.52 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 121.002 -1.061 . . . . 1.3 109.909 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' B' ' 52' ' ' THR . 48.6 mt -50.28 -53.12 30.82 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.53 -1.356 . . . . 0.4 108.988 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLN . . . . . 0.565 ' CD ' HH21 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -41.93 -18.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.217 -0.927 . . . . 2.24 110.653 -178.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' THR . . . . . 0.538 ' N ' ' O ' ' B' ' 50' ' ' LEU . 67.0 p -84.53 -9.9 57.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.466 -1.396 . . . . 0.4 110.449 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' LEU . . . . . . . . . . . . . 35.2 mt -94.75 117.46 30.16 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.892 -1.13 . . . . 0.36 109.223 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.81 91.92 0.8 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.475 -1.85 . . . . 0.42 108.475 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 27.1 mt -100.25 93.03 5.48 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.153 -1.204 . . . . 0.46 109.578 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 82.7 p -93.92 178.41 5.67 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.061 -1.025 . . . . 0.56 111.163 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -68.43 113.67 6.19 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.551 -0.718 . . . . 1.88 110.262 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.04 9.06 43.4 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.492 -1.443 . . . . 0.59 109.492 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 34.4 m -86.35 109.59 19.1 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.238 -1.154 . . . . 0.53 110.491 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' B' ' 7' ' ' THR . 44.0 t -77.25 115.64 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.252 1.025 . . . . 0.49 109.046 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 15.0 m -110.15 176.57 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 107.827 -1.175 . . . . 0.38 107.827 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -131.61 129.82 41.37 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.895 -1.15 . . . . 0.43 107.895 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -103.51 118.37 50.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 106.843 -1.54 . . . . 0.39 106.843 178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.1 p -119.74 132.54 55.66 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.835 -0.802 . . . . 1.31 108.835 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.13 151.46 38.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.073 -1.017 . . . . 0.5 109.866 -179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -145.45 124.14 12.56 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.6 -0.889 . . . . 2.09 108.6 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.47 -160.24 31.2 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.468 -1.349 . . . . 0.66 110.711 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -60.17 -49.94 75.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 122.165 -0.609 . . . . 2.15 112.329 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . 0.429 ' H ' ' HB3' ' B' ' 31' ' ' SER . 82.5 m-20 -106.92 11.01 30.39 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.786 -1.196 . . . . 1.51 111.566 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -40.67 -34.64 0.39 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.18 -0.95 . . . . 2.17 111.909 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -69.83 -42.3 73.8 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.682 -1.262 . . . . 2.41 110.613 -178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -68.91 -52.07 33.25 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.985 -1.072 . . . . 2.57 108.883 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -46.93 -36.44 7.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.594 -0.691 . . . . 0.73 111.555 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.556 ' O ' HG23 ' B' ' 78' ' ' VAL . 99.7 t -80.74 -37.73 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.391 -1.443 . . . . 0.56 109.984 179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -69.19 -38.15 78.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.761 -1.212 . . . . 2.19 110.917 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -82.3 -47.04 12.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.52 -1.362 . . . . 1.37 110.622 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 94.5 mt -59.84 -37.72 80.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.734 -1.229 . . . . 0.5 109.229 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 74' ' ' VAL . 47.6 t -62.48 -43.93 98.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.224 -0.922 . . . . 0.55 109.22 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' B' ' 83' ' ' GLU . 93.5 mttt -70.24 -56.14 7.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.839 -1.163 . . . . 2.16 107.89 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . . . . . . . . . 46.0 tp -54.01 -31.76 52.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.61 109.328 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' MET . . . . . . . . . . . . . 27.5 ttm -74.25 -38.42 63.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.66 -1.275 . . . . 1.52 108.256 176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -81.55 -5.39 57.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.297 -0.877 . . . . 0.75 110.134 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' B' ' 79' ' ' LYS . 2.9 mm-40 -110.24 -2.26 16.89 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.985 -1.072 . . . . 2.17 111.631 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 mt -83.28 129.98 35.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.379 -1.451 . . . . 1.05 109.493 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 117.941 -1.028 . . . . 2.44 109.523 -179.314 . . . . . . . . 0 0 . 1 stop_ save_